Ledger.Open graph →
SEC Form D · filed April 5, 2022

EnBiotix, Inc

Offering
$5.0M
Sold
$3.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Roberto D. Guttmann · Boston, MADirectorDaniel D. Hartman · Boston, MADirectorJeffrey D. Wager · Boston, MAExec · DirectorEdward J. Benz, Jr · Aspen, CODirectorSteve C. Gorlin · Aspen, CODirectorJohn C. Thomas, Jr · Aspen, COExec · DirectorDennis D. Auisello · Boston, MADirectorChristopher S. Valentino · Colchester, VTDirectorJared S. Vanarsdale · Colchester, VTDirectorThomas H. Rainey · Colchester, VTExec · DirectorDennis D. Auisello · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗